{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009624","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.378234+00:00","generated_at":"2026-06-01T00:30:16.500443+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Fortress Biotech issues 2.03M shares of common stock to settle Urica Preferred Stock obligations","bullets":["Issued 2,028,345 shares of common stock to former holders of Urica Preferred Stock.","Satisfied cumulative dividends and mandatory tender under Dividend Agreement dated Dec 27, 2022.","Fortress elected shares instead of cash; paid $20,747.62 for fractional shares and unpaid dividends.","Shares issued under Section 4(a)(2) exemption; resale registered effective June 27, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009624","json":"https://secwatch.observer/filing/0001558370-24-009624.json","markdown":"https://secwatch.observer/filing/0001558370-24-009624.md","text":"https://secwatch.observer/filing/0001558370-24-009624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024009624/0001558370-24-009624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024009624/fbio-20240627x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:30:16.500443+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}